HbA1c reductions are typically in the 1.0% to 1.4% range with oral semaglutide versus 1.5% to 1.8% with injectable
Blood sugar regulation changes on GLP-1 therapy as well
A C18 fatty acid modification at Lys30 enables albumin binding and a half-life of approximately 6 days, supporting once-weekly dosing
In two single-arm, open-label clinical trials comprising 37 children with MLD, Lenmeldy significantly reduced the risk of severe motor impairment or death compared with untreated children, according to the FDAs press release
Lip-1 Lip-1, a derivative of quinoxaline spirocyclic compounds, is a potent ferroptosis inhibitor first identified in 2014 through small molecule compound library screening (129)
Yes, Japan is included within Asia-Pacific under the regional scope of analysis